Clinical Trials Browser

Phase EARLY_PHASE1 × Lymphoma, Large B-Cell, Diffuse × Nivolumab × Clear all

NCT03311958 2025-04-06

Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance

Phase EARLY_PHASE1 Completed

Lymphoma, Large B-Cell, Diffuse